Revvity (NYSE:RVTY) Issues FY 2025 Earnings Guidance

Key Points

• Revvity updated its FY 2025 earnings guidance, projecting earnings per share (EPS) of $4.850-$4.950, slightly below the consensus estimate of $4.930, with revenue guidance set at $2.8 billion-$2.9 billion.
• On Monday, Revvity's stock fell by 8.3%, closing at $95.08, with trading volume significantly higher than its average.
• The company announced a quarterly dividend of $0.07 per share, representing a dividend yield of 0.29%, to be paid on November 7th to stockholders of record on October 17th.

Revvity (NYSE:RVTY - Get Free Report) updated its FY 2025 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 4.850-4.950 for the period, compared to the consensus estimate of 4.930. The company issued revenue guidance of $2.8 billion-$2.9 billion, compared to the consensus revenue estimate of $2.9 billion.

Revvity Trading Down 8.3%

Shares of Revvity stock traded down $8.59 during trading on Monday, hitting $95.08. The stock had a trading volume of 4,794,295 shares, compared to its average volume of 1,137,969. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.58 and a quick ratio of 2.99. Revvity has a 12 month low of $87.70 and a 12 month high of $129.50. The stock has a market cap of $11.21 billion, a PE ratio of 40.46, a PEG ratio of 2.61 and a beta of 0.98. The firm's fifty day simple moving average is $95.55 and its 200-day simple moving average is $103.13.

Revvity (NYSE:RVTY - Get Free Report) last announced its earnings results on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.14 by $0.04. Revvity had a return on equity of 7.73% and a net margin of 10.35%. The business had revenue of $720.28 million for the quarter, compared to analysts' expectations of $711.26 million. During the same quarter last year, the firm earned $1.22 EPS. The business's revenue for the quarter was up 4.1% on a year-over-year basis. As a group, sell-side analysts expect that Revvity will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 17th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.29%. The ex-dividend date of this dividend is Friday, October 17th. Revvity's dividend payout ratio (DPR) is 11.91%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the company. JPMorgan Chase & Co. lowered their price target on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 29th. Raymond James Financial restated an "outperform" rating and set a $120.00 price target (down from $145.00) on shares of Revvity in a research report on Tuesday, April 29th. The Goldman Sachs Group reduced their target price on shares of Revvity from $140.00 to $125.00 and set a "buy" rating on the stock in a report on Tuesday, April 29th. Evercore ISI reduced their price target on Revvity from $116.00 to $115.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Finally, Wall Street Zen upgraded shares of Revvity from a "hold" rating to a "buy" rating in a report on Saturday. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, Revvity presently has an average rating of "Moderate Buy" and an average price target of $123.07.

Hedge Funds Weigh In On Revvity

Hedge funds and other institutional investors have recently modified their holdings of the company. Focus Partners Wealth boosted its holdings in Revvity by 13.0% in the 1st quarter. Focus Partners Wealth now owns 7,028 shares of the company's stock worth $744,000 after acquiring an additional 811 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Revvity by 45.5% during the first quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company's stock worth $64,232,000 after purchasing an additional 189,871 shares in the last quarter. Millennium Management LLC boosted its stake in shares of Revvity by 102.0% in the first quarter. Millennium Management LLC now owns 69,401 shares of the company's stock valued at $7,343,000 after purchasing an additional 35,048 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Revvity by 6.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company's stock valued at $1,246,000 after purchasing an additional 744 shares during the period. Finally, AQR Capital Management LLC grew its holdings in Revvity by 5.2% during the 1st quarter. AQR Capital Management LLC now owns 8,449 shares of the company's stock valued at $883,000 after purchasing an additional 420 shares in the last quarter. 86.65% of the stock is owned by institutional investors and hedge funds.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.